RT Journal Article
T1 Addressing disparities and challenges in underserved patient populations with metastatic breast cancer in Europe.
A1 Vrdoljak, Eduard
A1 Gligorov, Joseph
A1 Wierinck, Lieve
A1 Conte, PierFranco
A1 De Grève, Jacques
A1 Meunier, Françoise
A1 Palmieri, Carlo
A1 Travado, Luzia
A1 Walker, Andrew
A1 Wiseman, Theresa
A1 Wuerstlein, Rachel
A1 Alba, Emilio
A1 Biurrún, Concepción
A1 D'Antona, Rosanna
A1 Sola-Morales, Oriol
A1 Ubaysi, Catherine
A1 Ventura, Roberta
A1 Cardoso, Fatima
K1 Cancer care disparities
K1 Challenges
K1 Europe
K1 Metastatic breast cancer
K1 Oncology
K1 Underserved patient population
AB People with metastatic breast cancer face many challenges and disparities in obtaining optimal cancer care. These challenges are accentuated in underserved patient populations across Europe, who are less likely to receive quality healthcare for reasons including socioeconomic inequalities, educational or cultural status, or geographic location. While there are many local and national initiatives targeted to address these challenges, there remains a need to reduce disparities and improve access to healthcare to improve outcomes, with a focus on multidisciplinary stakeholder engagement. In October 2019, a range of experts in metastatic breast cancer, including healthcare professionals, patient representatives, policymakers and politicians, met to discuss and prioritize the critical needs of underserved patient populations with metastatic breast cancer in Europe. Six key challenges faced by these communities were identified: the need for amplification of the metastatic breast cancer patient voice, better and wider implementation of high-quality guidelines for metastatic breast cancer, more collaboration between stakeholders, tailored support for patients from different cultural and ethnic backgrounds, improved data sharing, and work-related issues. The Expert Panel then conceived and discussed potential actionable goals to address each key challenge. Their conclusions present a set of interrelated approaches to address the different challenges and could serve as the basis for concerted improvement of the lives of patients with metastatic breast cancer in Europe.
YR 2020
FD 2020-12-13
LK http://hdl.handle.net/10668/16849
UL http://hdl.handle.net/10668/16849
LA en
DS RISalud
RD Apr 11, 2025